Identification of a novel domain of HIV Tat involved in monocyte chemotaxis

被引:105
作者
Albini, A
Benelli, R
Giunciuglio, D
Cai, T
Mariani, G
Ferrini, S
Noonan, DM
机构
[1] Ist Nazl Ric Canc, Ctr Biotechnol Avanzate, I-16132 Genoa, Italy
[2] Univ Genoa, Dipartimento Med Interna, I-16132 Genoa, Italy
关键词
D O I
10.1074/jbc.273.26.15895
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human immunodeficiency virus (HIV) Tat is chemotactic for monocytes and dendritic cells, an activity that could play a hey role in the expansion of HIV infection of accessory cells. To date, domains of Tat previously found to interact with cell surface molecules have shown only partial chemotactic activity toward monocytes. Using overlapping Tat peptides, we identify a novel region of Tat with a potent chemotactic activity for monocytes, reaching levels equal to Tat itself. This peptide also provokes monocyte polarization similar to Tat and is able to compete with Tat for induction of monocyte migration. Specific high affinity (k(d) = 3 x 10(-9) M) cell surface binding sites on monocyte cell surfaces for this region of Tat are demonstrated. These data indicate that the majority of Tat effects on monocytes are mediated by a novel region in the cysteine-rich and core domains. These domains are highly conserved among different HIV isolates, suggesting an important role in the establishment of HIV infection.
引用
收藏
页码:15895 / 15900
页数:6
相关论文
共 41 条
[1]   ANGIOGENIC POTENTIAL IN-VIVO BY KAPOSIS-SARCOMA CELL-FREE SUPERNATANTS AND HIV-1 TAT PRODUCT - INHIBITION OF KS-LIKE LESIONS BY TISSUE INHIBITOR OF METALLOPROTEINASE-2 [J].
ALBINI, A ;
FONTANINI, G ;
MASIELLO, L ;
TACCHETTI, C ;
BIGINI, D ;
LUZZI, P ;
NOONAN, DM ;
STETLERSTEVENSON, WG .
AIDS, 1994, 8 (09) :1237-1244
[2]   ANGIOGENIC PROPERTIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN [J].
ALBINI, A ;
BARILLARI, G ;
BENELLI, R ;
GALLO, RC ;
ENSOLI, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :4838-4842
[3]  
Albini A, 1996, ONCOGENE, V12, P289
[4]   The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells [J].
Albini, A ;
Soldi, R ;
Giunciuglio, D ;
Giraudo, E ;
Benelli, R ;
Primo, L ;
Noonan, D ;
Salio, M ;
Camussi, G ;
Rockl, W ;
Bussolino, F .
NATURE MEDICINE, 1996, 2 (12) :1371-1375
[5]   AIDS research - HIV's other immune-system targets: Macrophages [J].
Balter, M .
SCIENCE, 1996, 274 (5292) :1464-1465
[6]   THE TAT PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, A GROWTH-FACTOR FOR AIDS KAPOSI-SARCOMA AND CYTOKINE-ACTIVATED VASCULAR CELLS, INDUCES ADHESION OF THE SAME CELL-TYPES BY USING INTEGRIN RECEPTORS RECOGNIZING THE RGD AMINO-ACID-SEQUENCE [J].
BARILLARI, G ;
GENDELMAN, R ;
GALLO, RC ;
ENSOLI, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :7941-7945
[7]   Monocyte-derived dendritic cells and monocytes migrate to HIV-Tat RGD and basic peptides [J].
Benelli, R ;
Mortarini, R ;
Anichini, A ;
Giunciuglio, D ;
Noonan, DM ;
Montalti, S ;
Tacchetti, C ;
Albini, A .
AIDS, 1998, 12 (03) :261-268
[8]   TAT TRANS-ACTIVATES THE HUMAN IMMUNODEFICIENCY VIRUS THROUGH A NASCENT RNA TARGET [J].
BERKHOUT, B ;
SILVERMAN, RH ;
JEANG, KT .
CELL, 1989, 59 (02) :273-282
[9]   TAR-INDEPENDENT ACTIVATION OF THE HIV-1-LTR - EVIDENCE THAT TAT REQUIRES SPECIFIC REGIONS OF THE PROMOTER [J].
BERKHOUT, B ;
GATIGNOL, A ;
RABSON, AB ;
JEANG, KT .
CELL, 1990, 62 (04) :757-767
[10]   IDENTIFICATION OF AN ARG-GLY-ASP (RGD) CELL-ADHESION SITE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSACTIVATION PROTEIN, TAT [J].
BRAKE, DA ;
DEBOUCK, C ;
BIESECKER, G .
JOURNAL OF CELL BIOLOGY, 1990, 111 (03) :1275-1281